Skip to main content

Year: 2023

Andes Technology Unveils Andes D23 and N225 Cores Pioneering the Next Generation of Compact, Performant, and Secure RISC-V Processor Technology

Hsinchu, Taiwan, Oct. 17, 2023 (GLOBE NEWSWIRE) — Andes Technology, the renowned supplier of high-efficiency, low-power 32/64-bit RISC-V processor cores and a Founding Premier member of RISC-V International, proudly announces the release of its latest innovation – the AndesCore™ D23 and N225 RISC-V processors. Specifically designed to cater to the dynamic needs of the Internet of Things (IoT) and embedded systems, these cores epitomize Andes’ unwavering commitment to delivering cutting-edge technology for the interconnected world. The D23 and N225 cores have been meticulously engineered with compactness, performance-efficiency, low-power consumption, flexibility, and security as top priorities. These cores empower IoT and embedded chip and device manufacturers to meet the burgeoning demands of a rapidly evolving market while...

Continue reading

IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2023

Aggregated presentation by day and by marketName of issuer Identification code of issuer (Legal Entity Identifier) Day of transaction Identification code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares * Market (MIC Code)IPSEN 549300M6SGDPB4Z94P11 09/10/2023 FR0010259150 3 120.50 AQEUIPSEN 549300M6SGDPB4Z94P11 09/10/2023 FR0010259150 1,697 121.18 XPARIPSEN 549300M6SGDPB4Z94P11 10/10/2023 FR0010259150 232 121.80 AQEUIPSEN 549300M6SGDPB4Z94P11 10/10/2023 FR0010259150 34 122.00 TQEXIPSEN 549300M6SGDPB4Z94P11 10/10/2023 FR0010259150 1,288 121.67 XPARIPSEN 549300M6SGDPB4Z94P11 11/10/2023 FR0010259150 72 122.37 CEUXIPSEN 549300M6SGDPB4Z94P11 11/10/2023 FR0010259150 1,528 122.15 XPARIPSEN 549300M6SGDPB4Z94P11 12/10/2023 FR0010259150 24 120.80 TQEXIPSEN 549300M6SGDPB4Z94P11 12/10/2023 FR0010259150 1,676 121.29 XPARIPSEN 549300M6SGDPB4Z94P11 13/10/2023 FR0010259150 40 119.00 CEUXIPSEN 549300M6SGDPB4Z94P11 13/10/2023 FR0010259150 1,660 119.99 XPAR             *...

Continue reading

BUREAU VERITAS – Number of shares and voting rights as of September 30, 2023

REGULATED INFORMATION Neuilly-sur-Seine, France – October 17, 2023 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau VeritasDate Number of shares(1) Number of voting rights30/09/2023 453,871,520 Theoretical number of voting rights: 624,035,211 Number of exercisable voting rights: 623,772,560(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2023.                                 Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00Société Anonyme Immeuble Newtime Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 40/52 boulevard du Parc www.bureauveritas.comShare capital of EUR 54,449,462.40 92200 Neuilly-sur-Seine  RCS Nanterre...

Continue reading

The largest solar power plant in the Western Balkans Karavasta is now fully built and ready to generate power

The largest solar power plant in the Western Balkans Karavasta is now fully built and ready to generate power Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energy, announces that its Karavasta solar plant, with a capacity of 140 megawatts, located in the Fier district, south of Albania, is built and ready to generate power. On 17th October, as part of a State visit, the French President Emmanuel Macron and the Albanian Prime Minister Edi Rama welcomed in Tirana representatives from both Albanian and French branches of Voltalia. The Karavasta solar plant is the largest in Albania and indeed the largest in the Western Balkans. It is now built and is expected to produce its first megawatt-hours in the coming weeks. With a capacity of 140 megawatts, the plant can provide electricity equivalent to...

Continue reading

WISeKey Announces Nine Month 2023 Unaudited Revenue of $22.6 Million; Reports a 21% Increase from the Nine Month 2022 Period

WISeKey Announces Nine Month 2023 Unaudited Revenue of $22.6 Million; Reports a 21% Increase from the Nine Month 2022 Period WISeKey Charts Path for Revenue Expansion Beyond Cybersecurity and Semiconductors. ZUG, Switzerland – October 17 , 2023 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules– WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced nine month 2023 unaudited revenue of $22.6 million, for the period ended September 30, 2023, a 21% increase from the nine month period ended September 30, 2022. The company also ended the period with a strong cash position of $17 million. “We continue to achieve robust revenue performance in an ever-evolving market,”...

Continue reading

Ultimovacs Announces NIPU Results Presented at ESMO 2023: Significant and Clinically Meaningful Improvement in Overall Survival for Patients Receiving UV1 Cancer Vaccine in Phase II NIPU Trial in Malignant Mesothelioma

  UV1, in combination with the checkpoint inhibitors ipilimumab and nivolumab from Bristol-Myers Squibb, demonstrated a clinically meaningful overall survival benefit with no added toxicities, compared to ipilimumab and nivolumab alone, in the second-line treatment of patients with malignant mesothelioma The UV1 cancer vaccination combined with ipilimumab and nivolumab reduced the risk of death by 27%, meeting the protocol predefined threshold for statistical significance, in a hard-to-treat patient group with currently no standard-of-care treatment options First demonstration of universal cancer vaccine efficacy and therapeutic impact in a randomized Phase II clinical trial, supporting further clinical development NIPU results to be presented by the Principal Investigator Professor Åslaug Helland, MD, Ph.D., at the ESMO Congress 2023...

Continue reading

Press Release: Kering Beauté completes the acquisition of Creed

Press Release – Kering Beauté completes the acquisition of Creed_17 10 2023PRESS RELEASE  October 17, 2023KERING BEAUTÉ COMPLETES THE ACQUISITION OF CREED Kering Beauté announced today that it has completed the acquisition of the high-end luxury fragrance House Creed, in accordance with the terms disclosed on June 26th, 2023 and following clearance from the antitrust authorities. Creed will be consolidated in Kering accounts starting from November 1st, 2023. About Kering A global Luxury group, Kering manages the development of a series of renowned Houses in Fashion, Leather Goods and Jewelry: Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, Ginori 1735 as well as Kering Eyewear and Kering Beauté. By placing creativity at the heart of its strategy, Kering...

Continue reading

Global Non-Invasive Respiratory Therapy Market Size to Reach USD 3.94 Billion in 2032 | Emergen Research

Increasing prevalence of respiratory disorders is a key factor driving market revenue growth Vancouver, Oct. 17, 2023 (GLOBE NEWSWIRE) — The global non-invasive respiratory therapy market size was USD 2.33 Billion in 2022 and is expected to register a steady revenue CAGR of 5.3% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of respiratory disorders is a key factor driving market revenue growth. According to American College of Allergy, Asthma & Immunology, Asthma is responsible for 439,000 hospitalizations and 1.3 million emergency room visits per year. Asthma is the most frequent chronic condition in children, accounting for 13.8 million school days missed each year, which is also responsible for 14.2 million lost workdays among adults. The annual economic cost of asthma...

Continue reading

WithSecure Corporation, Inside information: Consulting goodwill impairment of EUR 6.2 million

WithSecure Corporation, Stock Exchange Release (Inside information), 17 October 2023, 17:30 EET WithSecure Corporation, Inside information: Consulting goodwill impairment of EUR 6.2 million As part of the preparation of its third quarter interim report, WithSecure has tested the values of the intangible assets and goodwill. As a result of this testing, an impairment of EUR 6.2 million of the goodwill related to consulting business will be recognized as part of the third quarter interim report result. The impairment will not have an impact on WithSecure cashflow or Adjusted EBITDA. Consulting goodwill is resulting from the acquisition of nSense (Denmark) in 2015, Inverse Path (Italy) in 2017, Digital Assurance (UK) in 2017, and MWR Infosecurity (UK) in 2018. In 2023, WithSecure lowered the revenue outlook of its consulting business, due...

Continue reading

Gray Issues Investor Deck Addressing Network and Retransmission Landscape

ATLANTA, Oct. 17, 2023 (GLOBE NEWSWIRE) —  Gray Television, Inc. (“Gray”) (NYSE: GTN) has released a new investor presentation providing Gray’s perspective on the broadcast industry and the company in the current network and retransmission landscape. The presentation outlines Gray’s belief that the Broadcast Industry and Gray are positioned well for continued growth in retransmission revenues in light of the continuing market trends and recent industry developments. The presentation is available on Gray’s website at https://gray.tv/investorrelations#presentations. Forward-Looking Statements: This press release and the presentation contains certain forward-looking statements that are based largely on Gray’s current expectations and reflect various estimates and assumptions by Gray. These statements may be identified by words such...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.